Merck Establishes New Foundation for Global Healthcare Solutions
Merck Group announced the establishment of the Merck Foundation, a non-profit limited liability company. Through this foundation, Merck combines many of its corporate responsibility activities under one roof and considerably expands its scope to address health, social and economic challenges of the 21st century.
“The vision of the new foundation is the world where everyone can lead a healthy and fulfilling life, also those living under disadvantaged conditions,” said Frank Stangenberg-Haverkamp, chairman of the board of trustees of the new foundation.

“With the Merck Foundation, we will continue our commitment towards improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and advancing people’s lives through science and technology,” added Haverkamp.
“The Merck Foundation will focus on initiatives that will contribute towards the sustainable development goals outlined by the United Nations. To achieve the foundations’ goals, we will develop and implement coherent strategies, result oriented programs and initiatives, provide grants to support projects and help raise funds where needed,” said Rasha Kelej, who has been appointed CEO of the Merck Foundation.
Kelej (45) joined Merck in 1996, working exclusively in positions relevant to corporate responsibility and market development with a strong focus on Africa and developing countries.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Merck Completes Sale of Surface Solutions Business to GNMI for €665 Million
-
Merck and Siemens Collaborate on Smart Manufacturing
-
Merck sells Surface Solutions to Global New Material International for €665 million in cash
-
Merck Group acquires chip equipment supplier Unity-SC for €155 million
-
Merck Launches Commercial Production of First GMP-Compliant Cell Culture Media Production Line in China
-
Merck to acquire EyeBio for $3 billion
-
Circa signs OEM agreement with Merck to supply and sell Cyrene
-
The Rising Heat of DAC Drugs: ADC and PROTAC Sparking Innovation
Recommend Reading
-
$2.43 Billion Deal: Olin Buys Huntsman
-
Ashland Explores Sale as Private Equity Circles $4.5 Billion Specialty Chemicals Portfolio
-
INEOS Closes US Polystrene Plant: 400K Tons of PD in the US Can't Hold On
-
Evonik Cuts 3,200 Jobs: Europe’s Chemical Winter Is Not Over
-
Overseas Up, China Down: The Global MDI Market Is Splitting Apart
-
Business Society’s Market Outlook for Phthalic Anhydride on August 11, 2026: Continuing Downward Trend
-
Business Society August 10, 2026 Hydrofluoric Acid Market View: Volatile (Bearish)
-
Business Society August 12, 2026 China Hydrofluoric Acid Market Perspective: Prices in a Fluctuating Trend
-
Business Society’s DOP Market Outlook on August 11, 2026: Slightly Bullish with Volatility
-
Cost support weakens and demand declines, phthalic anhydride prices fall in August in China
- Hot Searches
- biotrend corporation
- scoplomaine
- hong kong chemical reagent suppliers
- reiser emulisfier
- pvc resin price
- polypropylene index price
- carboxy methyl cellulose price
- food defoamer
- potassium cyanide purchase
- grey market retatrutide price
- teriparatide injection
- methyl ethyl ketone peroxide mekp